Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Masked, Multi-center, Active Controlled Safety and Efficacy Study of Adjunct Episcleral Brachytherapy for Polypoid Choroidal Vasculopathy

NCT05251636 is registered in ClinicalTrials.gov with Salutaris Medical Devices, Inc. as lead sponsor.

NCT NCT05251636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05251636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Masked, Multi-center, Active Controlled Safety and Efficacy Study of Adjunct Episcleral Brachytherapy for Polypoid Choroidal Vasculopathy
Lead sponsor
Salutaris Medical Devices, Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
September 30, 2028
Enrollment
159 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, polypoid choroidal vasculopathy